CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

J Wang, R Zhang, Z Lin, S Zhang, Y Chen… - Journal of Hematology & …, 2020 - Springer
Background The cyclin-dependent kinase 7 (CDK7) subunit of TFIIH regulates RNA
polymerase-II-based transcription and promotes tumor progression. However, the …

Drugging hijacked kinase pathways in pediatric oncology: Opportunities and current scenario

MF Candido, M Medeiros, LC Veronez, D Bastos… - Pharmaceutics, 2023 - mdpi.com
Childhood cancer is considered rare, corresponding to~ 3% of all malignant neoplasms in
the human population. The World Health Organization (WHO) reports a universal …

[HTML][HTML] The application of patient-derived xenograft models in gynecologic cancers

W Jiang, S Xie, Y Liu, S Zou, X Zhu - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Recently, due to the limitations of cell line models and animal models in the preclinical
research with insufficient reflecting the physiological situation of humans, patient-derived …

Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer

YB Shin, JY Choi, DH Shin, JW Lee - International Journal of …, 2023 - Taylor & Francis
Purpose We aimed to inhibit ovarian cancer (OC) development by interfering with
microtubule polymerization and inhibiting mTOR signaling. To achieve this, previously …

Identification of CDK7 inhibitors from natural sources using pharmacoinformatics and molecular dynamics simulations

V Kumar, S Parate, G Thakur, G Lee, HS Ro, Y Kim… - Biomedicines, 2021 - mdpi.com
The cyclin-dependent kinase 7 (CDK7) plays a crucial role in regulating the cell cycle and
RNA polymerase-based transcription. Overexpression of this kinase is linked with various …

NANOG regulates epithelial–mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV‐3 and A2780 cells

H Yun, GH Han, J Kim, JY Chung… - Journal of Cellular …, 2022 - Wiley Online Library
NANOG engages with tumour initiation and metastasis by regulating the epithelial–
mesenchymal transition (EMT) in epithelial ovarian cancer (EOC). However, its role in …

Targeting mutated p53 dependency in triple-negative breast cancer cells through CDK7 inhibition

J Peng, M Yang, R Bi, Y Wang, C Wang, X Wei… - Frontiers in …, 2021 - frontiersin.org
Background Cyclin-dependent kinase 7 (CDK7) is crucial for cell cycle progression and
gene expression transcriptional regulation, which are often not assessed in cancer …

DNA repair pathway in ovarian cancer patients treated with HIPEC

D Flasarova, K Urban, O Strouhal, D Klos… - International Journal of …, 2023 - mdpi.com
DNA repair pathways are essential for maintaining genome stability, and understanding the
regulation of these mechanisms may help in the design of new strategies for treatments, the …

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer

D Howard, D James, J Garcia-Parra… - Frontiers in …, 2022 - frontiersin.org
Background Ovarian cancer (OC) is amongst the most lethal of common cancers in women.
Lacking in specific symptoms in the early stages, OC is predominantly diagnosed late when …

RETRACTED: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma

H Ma, DC Dean, R Wei… - Therapeutic advances …, 2021 - journals.sagepub.com
Background: Overexpression of cyclin-dependent kinase 7 (CDK7) is a well-known
pathogenic feature of various malignancies and a sign of a more dismal prognosis. As …